July 2017 tender notification

Tender Closed

PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2015/16 Invitation to Tender, dated 6 November 2015 and the 2016/17 Invitation to Tender, dated 3 November 2016.

Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change.  More information and NOPC forms can be found on our website(external link).

Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand (http://www.pgnz.org.nz/pharmacode(external link)) and that a CTPP code has been obtained from the New Zealand Universal List of Medicines (http://www.nzulm.org.nz/sponsors(external link)). Pharmacodes and CTPP codes must be provided to PHARMAC by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest). PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.

2015/16 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2019

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

1. Tenders awarded to listed pharmaceuticals where no brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type

Pack price
Hospital Supply Brand (Supplier) DV Limit Listing date Hospital Supply Status date
Droperidol Inj 2.5 mg per ml, 1 ml ampoule, 10 ampoules $35.00 Droperidol Panpharma (Multichem) 1% 1 April 2018 1 June 2018

2016/17 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2020

Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

2. Tenders awarded to listed pharmaceuticals where no other brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Current
pack price
New
pack price
Sole supply brand
(Supplier)
Date of subsidy change Sole Subsidised Supply date
Amitriptyline* Tab 10 mg, 100 tablets, blister pack $1.68 $1.96 Arrow-Amitriptyline
(Actavis)
1 February 2018 1 May 2018
Amitriptyline* Tab 25 mg, 100 tablets, blister pack $1.68 $1.52 Arrow-Amitriptyline
(Actavis)
1 February 2018 1 May 2018
Amitriptyline* Tab 50 mg, 100 tablets, blister pack $2.82 $2.51 Arrow-Amitriptyline
(Actavis)
1 February 2018 1 May 2018
* These products will be supplied at the Price from the 1st day of the month prior to the listing date, as per Schedule 5, clause 3.1 (b) (II) of the 2016/17 Invitation To Tender

3. Tenders awarded to listed pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Current
pack price
New
pack price
Sole Supply Brand
(Supplier)
Date of listing/
subsidy change
for tender
winning brand
Date of reference
pricing of other
listed brands
Sole Subsidised Supply date
(and delisting of other listed
brands)
Brand (Supplier) affected by reference pricing and
delisting
Amoxicillin Oral liquid 125 mg per 5 ml,
100 ml bottle
$0.88* $1.20 Alphamox 125
(Myan)
1 December 2017 N/A 1 May 2018 Ospamox (Sandoz)
Amoxicillin Actavis (Actavis)
Amoxicillin Oral liquid 250 mg per 5 ml,
100 ml bottle
$0.97* $1.31 Alphamox 250
(Mylan)
1 December 2017 N/A 1 May 2018 Ospamox (Sandoz)
Amoxicillin Actavis (Actavis)
* Note the price/subsidy of these products is higher for Ospamox

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

4. Tenders awarded to listed pharmaceuticals where no other brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Current
pack price
New
pack price
Hospital Supply Brand
(Supplier)
DV Limit Listing date Hospital Supply Status date
Amitriptyline* Tab 10 mg, 100 tablets, blister pack $1.68 $1.96 Arrow-Amitriptyline (Actavis) 1% 1 February 2018 1 April 2018
Amitriptyline* Tab 25 mg, 100 tablets, blister pack $1.68 $1.52 Arrow-Amitriptyline (Actavis) 1% 1 February 2018 1 April 2018
Amitriptyline* Tab 50 mg, 100 tablets, blister pack $2.82 $2.51 Arrow-Amitriptyline (Actavis) 1% 1 February 2018 1 April 2018
* These products will be supplied at the Price from the 1st day of the month prior to the listing date, as per Schedule 6, clause 3.1 (b) (II) of the 2016/17 Invitation To Tender

5. Tenders awarded to listed pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Current
pack price
New
pack price
Hospital Supply Brand
(Supplier)
DV Limit Listing date Hospital Supply Status date Brand (Supplier) affected by
delisting
Amoxicillin Oral liq 125 mg per 5 ml, 100 ml
bottle
$0.88* $1.20 Alphamox 125
(Myan)
1% 1 December 2017 1 February 2018 Ospamox (Sandoz)
Amoxicillin Actavis (Actavis)
Amoxicillin Oral liq 250 mg per 5 ml, 100 ml
bottle
$0.97* $1.31 Alphamox 250
(Myan)
1% 1 December 2017 1 February 2018 Ospamox (Sandoz)
Amoxicillin Actavis (Actavis)
* Note the price/subsidy of these products is higher for Ospamox

Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status

PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in:

  • the 2015/16 Invitation to Tender, dated 6 November 2015, and
  • the 2016/17 Invitation to Tender, dated 3 November 2016.

2015/16 Invitation to Tender

Chemical name Line item
Baclofen Inj 2 mg per ml, 5 ml
Mycophenolate mofetil Cap 250 mg
Mycopheolate mofetil Tab 500 mg

2016/17 Invitation to Tender

Chemical name Line item
Aprepitant Cap 2 x 80 mg and 1 x 125 mg
Bumetanide Tab 1 mg
Ceftazidime Inj 2 g
Doxycycline hydrochloride Tab 100 mg

For products included in the 2015/16 and 2016/17 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.

If you have any queries regarding this notification, please contact PHARMAC on 0800 66 00 50.